Pharma Traders Private Limited - Due diligence report

A 360° intelligence report on Pharma Traders Private Limited: trust score, financial health, credit view, compliance, directors, growth and …

2001-01-03 Indore, Madhya Pradesh Active Unlisted Active Compliant
Share
PT Pharma Traders Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Pharma Traders Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
59/100
Trust Score
Moderate

Pharma Traders Private Limited is assessed as Moderate with a Trust Score of 59/100. Pharma Traders Private Limited is an active private limited indian non-government company incorporated in 2001, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Pharma Traders Private Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
59/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
50/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
30/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • Profitable - internal accruals available.

Charges position: 1 open (3.00 cr) · 8 satisfied (39.16 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others1 48.0 cr
Tata Capital Financial Services Limited1 48.0 cr
State Bank Of India1 48.0 cr
Au Financiers (India) Limited1 48.0 cr
State Bank Of Indore2 48.0 cr
Axis Bank Limited2 48.0 cr
Compliance Score: 50/100 Moderate
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: NCLT, BANKS.
  • Litigation present in 3 court forum(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
GULAB AGRAWAL 01234567 Director 01/04/2018 6 yrs Approved
SUBHASH AGRAWAL 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2016)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: SUBHASH AGRAWAL (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 55
Growth signals & trust indicators
Operating for 25+ years.
Active EPFO - real payroll on record.
Distress signals & risk flags
Revenue declined year-on-year.
Negative net worth.
Compliance score is weak (50/100).
1 open charge(s) registered - assets are encumbered.
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence54/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment44/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 3.00 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view41/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
23 Mar 2022
Charge satisfied
Intec Capital Limited
11 Feb 2022
Charge satisfied
Others
04 Dec 2020
Charge satisfied
State Bank Of India
29 Nov 2019
Director ceased
Shreyas Sancheti
08 Jan 2016
Charge satisfied
Axis Bank Limited
24 Nov 2015
Charge satisfied
Tata Capital Financial Services Limited
09 Feb 2015
Charge created
Au Financiers (India) Limited - 3.00 cr
31 Oct 2013
Charge created
Intec Capital Limited - 1.19 cr
20 Aug 2013
Charge created
State Bank Of India - 3.40 cr
14 Aug 2012
Charge created
Axis Bank Limited - 1.00 cr
15 Mar 2012
Securities allotted
1538461.00 Equity Shares - 1.54 cr raised
30 Nov 2011
Securities allotted
500000.00 Equity Shares - 50.00 Lakh raised
30 Jun 2011
Charge created
Axis Bank Limited - 1.00 cr
10

Key Observations

Auto-generated from the data above
Revenue declined 38% over the last 4 financial year(s).
2 active director(s) / partner(s); board looks stable and experienced.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Viruksham Enterprises Private Limited U51909TN2020PTC139072 Chennai, Tamil Nadu, India
Pasupati Expo India Private Limited U74999WB2011PTC163718 Kolkata, West Bengal, India
Singh Engineering & Services Private Limited U74120DL2013PTC255963 New Delhi, Delhi, India
Fawes Lifestyle Private Limited U52399MH2021PTC368014 Mumbai, Maharashtra, India
Sainish Pharma Private Limited U24232PB2008PTC032387 Bathinda, Punjab, India
Sovan Biosciences Private Limited U24239UP2019PTC121190 Kidwai Nagar, Uttar Pradesh, India
Digisagar Marketing Private Limited U80904DL2019PTC352580 New Delhi, Delhi, India
Tristar Chemicals & Coatings Private Limited U74999WB2017PTC222153 Purba Medinipur, West Bengal, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Pharma Traders Private Limited before audits and certifications: compliance score 50/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Pharma Traders Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Pharma Traders Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 59/100, distress signals and MSME payment-delay disclosures - know whether Pharma Traders Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Pharma Traders Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Pharma Traders Private Limited an active company?

Pharma Traders Private Limited has MCA status “Active” with a compliance score of 50/100 (Moderate).

Is Pharma Traders Private Limited financially healthy?

Pharma Traders Private Limited has a Financial Health Score of 30/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Pharma Traders Private Limited?

Its overall Trust Score is 59/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Pharma Traders Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Pharma Traders Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 8 earlier charge(s) stand satisfied.

Is Pharma Traders Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 50/100 (Moderate).

Is it risky to lend to Pharma Traders Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.